SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ANDRX (ADRX) -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (77)4/27/1998 9:14:00 AM
From: Sandra  Read Replies (1) | Respond to of 127
 
Richard,
I wouldnt count on your assumptions with MDIX.

<<There are a lot of things being claimed on the MDIX thread. I, for one, assume that
MDIX will be bankrupt by the time that a judge or jury can award punitive damages, and
that the MDIX affair will thus have little impact on ADRX other than the hassle factor.>>

Sandra



To: scaram(o)uche who wrote (77)4/28/1998 4:22:00 AM
From: cool  Respond to of 127
 
I am sure ADRX is a fine company and no critism was intended in my comments re the software dispute with
MDIX. My point was that perhaps ADRX, which said they
purchased their software from another source, bought the product without knowing that MDIX had already had purchased exclusive rights.

ADRX' dispute may be with whomever they purchased the
software from or the ARDX employee responsible for their
'in house' software development.

JL


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News